Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Safety monitoring and information (143)
- Compliance and enforcement (36)
- Import and export (36)
- Shortages and supply disruptions (16)
- Sunscreens (10)
- Advertising (7)
- COVID-19 (5)
- Labelling and packaging (5)
- Weight loss products (5)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Cosmetics (1)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
1313 result(s) found, displaying 1176 to 1200
-
Safety alertsThe Therapeutic Goods Administration (TGA) has become aware that the caps on some children's liquid medicines may require tightening to ensure the child-resistant closure is activated correctly.
-
Safety alertsGinkgo biloba products with high quercetin and rutin levels have been identified. Quality standards are being reviewed.
-
Safety alertsPanvax H1N1 influenza vaccine has been approved for use in adults and children over 10 years old, with additional data needed for younger children.
-
Market actionsThe bolts used to secure the caster assemblies to the wheelchair frame can fail in use.
-
Safety alertsAdvise to exercise caution when using Australian Hydroxycut products
-
Market actionsChuan Xiong Cha Tiao Wan pills have been recalled due to the presence of aristolochic acids, which can cause severe kidney damage and urinary tract cancer. Stop using them immediately and consult your doctor for advice.
-
Market actionsChuan Xiong Cha Tiao Wan pills (recall notice)
-
-
-
Market actionsThese products have been associated with a small number of serious allergic reactions
-
Market actions2008 recall of Nyal herbal cold and flu products.
-
Safety alertsUpdated web advisory.
-
Market actionsThe fat loss capsules were illegally supplied to the market. The prescription-only (S4) medicines Sibutramine and Phenolphthalein were detected in a sample.
-
Safety alertsUpdated web advisory.
-
Safety alertsUpdated web advisory.
-
Safety alertsUrgent web advisory.
-
Market actions2008 recall of Nutrex Research Lipo 6 liquid capsules.
-
Market actionsA number of brands of hot/cold gel packs are being recalled following testing by the Therapeutic Goods Administration (TGA) of contents for ethylene glycol, a toxic substance.
-
Market actionsRecall due to product containing the toxic substance ethylene glycol (rather than the non-toxic ingredient propylene glycol).
-
Market actionsA number of brands of hot/cold gel packs are being recalled following testing by the Therapeutic Goods Administration (TGA) of contents for ethylene glycol, a toxic substance. Testing was undertaken following the previous recall of Thermoskin® hot/cold gel packs to determine if the problem was more widespread.
-
Market actionsRecall due to product containing the toxic substance ethylene glycol (rather than the non-toxic ingredient propylene glycol).
-
Market actionsThe Therapeutic Goods Administration (TGA) advised on 2 September 2008 that the Thermoskin® brand of hot/cold gel packs was being recalled after testing revealed that they contained the toxic substance ethylene glycol, rather than the non-toxic ingredient propylene glycol.
-
-
Market actionsRecall letters will be dispatched by the sponsor to pharmacies from Tuesday 16 September 2008.
-
Market actionsRecall due to product containing the toxic substance ethylene glycol (rather than the non-toxic ingredient propylene glycol).